StockWatch
·
INDIQUBE SPACES · Q2 FY27 · THE VERDICT

₹63 Crore PAT Gap Undermines Revenue Growth Story

Revenue grew 35% to ₹471.9 crore, but net profit swung to a ₹5.9 crore loss—contradicting management's ₹57 crore claim on the call. The disconnect reveals a credibility gap that the stock is now pricing in.

Q2 FY27 resultsINDIQUBEIndiqube Spaces Ltd11 Nov 2026 · 6 min read
Reported revenue

₹471.9 Cr

+34.8% YoY

Reported PAT

-₹5.9 Cr

loss, vs ₹57 Cr claimed

EBITDA margin (guided)

19–21%

range-bound; Q2 claimed 22%

Occupancy

86–87% Q2

vs 89% Q1, 91% target

The headline is muscular: revenue up 35% to ₹471.9 crore, anchored in strong global capability centre (GCC) and ESG-driven demand (54% of revenue). But beneath the topline sits a profitability crater that management never reconciled. On the call, executives claimed Q2 net profit of ₹57 crore. The delivered result: a loss of ₹5.9 crore. That is a ₹63 crore swing with no disclosure on the call of why. Occupancy also dipped to 86–87% in Q2, contradicting management's assertion of 91% steady-state occupancy. The market—down 24% from its all-time high—is right to be skeptical.

Where the profit disappeared

Half-year (H1) net profit was ₹92 crore on ₹904 crore revenue. Q2 loss of ₹5.9 crore means Q1 was roughly ₹98 crore—a dramatic cliff. The likely culprits, none disclosed on the call: (1) pre-operating costs on the 1.5 million sq ft of new supply added year-to-date (ramp-up costs before occupancy and profitability kick in); (2) depreciation and amortisation from new capex (solar, SaiEdge, retail pilot); (3) provisions or tax adjustments not flagged upfront. This matters because it transforms the PAT miss from "earnings surprise" to "temporary investment phase"—but only if management had been transparent about it, which it wasn't. Instead, the call re-guided EBITDA (19–21% range) while conspicuously omitting any re-statement of PAT margin (prior guidance 8–10%; Q2 actual -1.2% net profit margin). That silence is itself a signal.

Management claims vs. what the numbers actually say
What was claimed on the callWhat was deliveredVerdict
PAT ₹57 Cr, 63% YoY growthNet profit -₹5.9 Cr (loss), NPM -1.2%Contradicted (₹63 Cr swing, no reconciliation)
Revenue ₹475 Cr, 34% growth₹471.9 Cr, 34.8% growthSupported (minor rounding)
Occupancy improved to 91%86–87% Q2 vs 89% Q1Contradicted (dipped, not improved)
EBITDA ₹105 Cr, 22% marginOperational margin 62.8%; EBITDA vs EBIT distinction unclearUnverified (confusion on margin type)
PAT margin 8–10% (prior guidance)-1.2% actual; not re-stated on callWithdrawn implicitly (hedging signal)

What shifted on this call

Three key changes frame the near-term outlook: (1) PAT margin guidance withdrawn. Prior FY27 guidance was 8–10% PAT margin. Call delivered -1.2% in Q2 and re-guided EBITDA (19–21%) but refused to re-state PAT margin, signalling management's loss of confidence in profitability near-term. (2) Occupancy ramp timeline extended. New supply (1.5M sq ft added so far of a 2M target) typically needs 6–12 months to reach 90% occupancy and cash-breakeven. Management now frames the range-bound 80–90% occupancy as 'healthy headroom' rather than an interim state—implying H2 ramp may slip. (3) Solar capex plan confirmed with payback disclosed. ₹100–120 crore capex FY27 (repeating next year) to expand from 30 MW to 60 MW capacity. Payback: 3 years; ₹30 crore annual revenue run-rate at ₹15 crore H1 pace. No new margin impact yet (treated as capex), but this is a multi-year drag on ROCE until payback cycles.

The bull-bear ledger

  • Bull case: Revenue growth 34.8% YoY is real; anchored in GCC/ESG tailwind (54% revenue from global capability centres, a durable secular trend). Client lock-in averaging 42 months with 80% renewal at same or escalated terms shows stickiness. Solar expansion to 60 MW over 3 years creates a capex moat.

  • Bear case: PAT swing ₹57 Cr → -₹5.9 Cr with zero reconciliation from management. Occupancy dipped to 86% and near-term ramp is now 6–12 months out. EBITDA margin held (19–21% range) but at the cost of profitability; if occupancy lags, EBITDA could compress too. ₹100+ Cr annual capex (solar + SaiEdge micro-market sourcing + retail pilot) suppresses near-term ROE.

  • The honest read: Long-term ESG/GCC play is intact (30%+ growth runway for 5+ years). But near-term execution credibility is shaken. Occupancy volatility (80–90% range) and pre-operating drag on profitability are real, not transient—until proven otherwise. The ₹63 crore PAT gap and management's silence on it is a red flag, not a rounding error.

How the market is reading this

The stock is down 23.7% from its all-time high of ₹243.8, now trading at ₹185.99. RSI sits at 54.1 (neutral); volume is declining. Foreign institutional investors (FIIs) have trimmed by 2 basis points (Q1 FY27: 2.16% vs Q4 FY26: 2.18%), a signal of minor but deliberate exit. Domestic institutional investors (DIIs) are flat (-35 basis points to 14.35%), neither defending nor aggressively adding. Promoters hold steady at 60.1%.

What this positioning means: The market is pricing in execution risk and credibility loss. A 24% drawdown from ATH is not a crash—it reflects justified caution, not panic. The buyer of the last dip was not convinced enough to hold, and the seller near the high was right to trim. FII exit, while modest, signals that foreign money sees better-positioned long-term plays in higher-quality, lower-leverage growth stories. The holdout is domestic money and promoters—a mix that often signals 'waiting for a recovery print' rather than 'deep conviction.'

What to watch next
  • 1 · Q3 occupancy trajectory

    Does occupancy ramp from 86–87% toward 90%+? New supply (1.5M added YTD) should reach 50–60% occupancy breakeven in Q3–Q4. If it stalls below 85%, the entire 2M-sq-ft expansion thesis falters. Track rent-paying area and occupancy % separately—revenue can grow without margin if occupancy lags.

  • 2 · H2 PAT recovery and D&A accounting

    Does Q3–Q4 PAT rebound to ₹40–50 Cr range (gross average if H1 was ₹92 Cr)? If PAT remains negative or depressed, the Q2 loss was not one-time but structural margin compression. Management should reconcile what drove the Q2 loss (provisions, tax, D&A) and confirm it does not repeat.

  • 3 · Solar capex realization and payback timeline

    Is solar deployed on schedule (30 MW→60 MW pipeline) and is the ₹30 Cr annual revenue payback being achieved? ₹15 Cr H1 pace would reach ₹30 Cr run-rate by end-FY28, supporting 3-year thesis. If revenue underperforms or capex overruns, ROCE headwinds persist.

  • 4 · SaiEdge and retail branch pilot traction

    Management framed these as 'pilot' and 'early stage.' ₹35 Cr SaiEdge investment and retail capex (~30 branches) are sunk costs unless they prove unit economics. A miss here defers ROE recovery to FY28+.

The quarter is a transition, not a permanent step-down. Revenue is real and GCC/ESG tailwinds are concrete. But the ₹63 crore PAT gap and occupancy dip reveal that scaling—ramping 2M sq ft, deploying ₹100+ Cr solar, testing retail and SaiEdge—is not costless. Pre-operating expenses are real, and they're hitting the P&L sooner than management signalled.

For a holder: The long-term thesis (ESG capex moat, 30%+ growth, GCC stickiness) is intact. But your patience will be tested over the next 2–3 quarters. Watch Q3 for occupancy reversal and clean accounting reconciliation of Q2. If management can explain the PAT gap and print at least ₹30+ Cr PAT in Q3, the ₹185 price starts to look like a hold. If occupancy stalls and PAT remains negative, re-evaluate.

For a prospective buyer: The ₹185 level (down from ₹244 ATH) is a reasonable entry for a 3–5-year view, assuming you believe GCC hiring and ESG capex are structural. But do not chase it on the assumption of a near-term recovery pop. The credibility debt needs to be paid off first—with clean Q3 and Q4 prints.

The single number to track: Net profit margin in Q3 and Q4. If it rebounds to +3–5% (a healthy mid-cycle level for scaled operators in real estate), the story re-rates as a 'temporary investment phase.' If it stays negative or creeps to +1–2%, there is structural margin compression at play, and the ₹185 price is fair or high.

Informational and educational content only. Not investment advice.